Monique Dao Email & Phone Number

Monique Dao Work

• 2024 -now Consulting Head of Translational, Innate Immune Cell Engagers for Oncology @ Sauvie Inc.
• 2024 -now Consultant, In vivo Innate Immune Cell targeting for Alzheimer @ Stealth Mode
• 2025 -2026 Analytical Development @ Startup - iPSC cell therapy
• 2021 -2023 VP Pre-clinical and Translational Immunology, iPSC-Microglia and iPSC-Macrophage Therapy @ Elpis BioMed
• 2020 -2022 CMC consultant @ GentiBio
• 2020 -2021 Head of Cell Biology - Hypoimmune Cell Platform for Oncology @ Sana Biotechnology, Inc.
• 2019 -2020 Head of Preclinical Development - Gene editing of iPSC, MSC, HSC, and Treg cells @ Synthego Corporation
• 2019 -2019 Senior Director - Preclinical and Non-clinical - CAR Synthetic Circuit for Solid tumor @ Refuge Biotechnologies
• 2018 -2018 Director - CAR Synthetic Circuit - Process Optimization @ Refuge Biotechnologies
• 2017 -2018 Director, iPSC-T and iPSC-NK @ FUJIFILM Cellular Dynamics
• 2015 -2017 Senior Program Lead - TCR-engineered gamma delta T cell therapy @ Immatics
• 2014 -2015 Assistant Research Professor - AML Autologous CAR T Therapy @ City of Hope
• 2008 -2014 Senior Scientist - Drug Product Development for CNS inflammation @ SanBio, Inc.
• 2006 -2007 Foreign Postdoctoral Fellow - T cell signaling @ Institut de G
• 2024 -now Consultant, Innate Immune targeting for Alzheimer @ Stealth Mode
• 2021 -2023 VP Translational Immunology, iPSC-Microglia and iPSC-Macrophage Therapy @ Elpis BioMed